Jeffrey Meisles, MD
Orthopaedic Surgery · Elmhurst, ILNPI 1982606372
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $63,145 of the $67,447 with a category attached, or 93.6%. Medacta USA, Inc. accounts for 95.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $17,364 and has fallen 99.8% since, to $39 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $1729.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$65K
- Pacira Therapeutics, Inc.$2K
- Medwest Associates$261
- Catalyst Orthoscience$48
- Bioventus LLC$39
- Johnson & Johnson$23
- plus $20 from 1 others
What the payments were for
- Consulting fees$63,14594%
- Speaking & faculty fees$2,3754%
- Travel & lodging$7851%
- Food & beverage$1,1412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 31 | $64,637 |
| Pacira Therapeutics, Inc. | 2 | $2,420 |
| Medwest Associates | 1 | $261 |
| Catalyst Orthoscience | 1 | $48 |
| Bioventus LLC | 2 | $39 |
| Johnson & Johnson | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$21,410
- AMISTEM$14,218
- M-VIZION$6,800
- GMK Sphere Revision System$4,900
- Zilretta$2,375
- NEXTAR$125
How this compares
$67,447 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 111 | $383 |
| Celecoxib | 17 | $217 |
| Methylprednisolone | 15 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Elmhurst
- Ashish PatelElmhurst$1.1M
- Peter BonuttiEffingham$24.3M
- Steven HaddadGlenview$12.6M
- Aaron RosenbergChicago$12.4M
- Treg BrownHerrin$6.6M
- Wayne GoldsteinMorton Grove$4.9M
- Steven ChudikWestmont$4.1M
- Matthew SquireAurora$2.9M
- David ManningBurr Ridge$2.3M
- Ritesh ShahMorton Grove$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.